Effect of polypody rhizome on premenstrual symptoms
Not Applicable
Completed
- Conditions
- Health Condition 1: R398- Other symptoms and signs involvingthe genitourinary system
- Registration Number
- CTRI/2019/01/017118
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 66
Inclusion Criteria
Patients having a regular spontaneous menstrual cycle of 21 to 35 days presenting with signs and symptoms of premenstrual syndrome.
Patients having symptoms of PMS for atleast 3 menstrual cycles as per ACOG guidelines.
Exclusion Criteria
Patients presenting with irregular menstrual cycle.
Patients on oral contraceptives and lactating women.
Patients having any unstable medical illness and seizure disorder.
Diagnosed cases of psychosocial stresses, family, mood andpersonality stresses or depression disorders.
Patients with any systemic and endocrineillness like diabetes mellitus, thyroid dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Premenstrual syndrome symptomsTimepoint: At baseline, after 1st, 2nd, 3rd and 4th menstrual cycle
- Secondary Outcome Measures
Name Time Method Change in quality of life assessed by EQ-5D-5L questionnaireTimepoint: At baseline, After third menstrual cycle and fourth menstrual cycle